b型流感嗜血桿菌英文講義

1、b型流感嗜血桿菌英文講義Hib - characteristicsGram negative cocco-bacillicarried by 3% to 15% of young children in the worldcauses disease in young childrenmeningitispneumoniaepiglottitisseptic arthritisHib diseaseIndustrialized countriesmedian age 1-2 yearsmost meningitis then epiglottitis?meningitis mortality

2、under 5%affects 1-2/1000 childrenDeveloping countries (Africa)median age 6-9 monthsmost pneumonia, then meningitismeningitis mortality 20-50%affects 10/1000 children?Gambian PRP-T trial42,000 infants randomized to receive PRP-T or placebo at 2, 3 and 4 months of agepopulation studied for:Hib meningi

3、tisHib pneumoniaall pneumoniaHib carriageGambia slides courtesy of Kim Mulholland, MD University of MelbourneStudy designindividually randomized, double blind studymajor effort to detect Hib pneumoniarandomization in 10 groups numbered 0 through 9:DTP + PRP-TDTP + placeboat 2, 3 and 4 months of age5

4、 numbers5 numbersFinal results, March 199642,848 infants enrolledPRP-T group21,490 infants1272 possible Hib disease616 chest radiographs173 lumbar punctures71 lung aspiratesControl group21,358 infants1342 possible Hib disease653 chest radiographs192 lumbar punctures75 lung aspiratesDid the vaccine a

5、ctually prevent pneumonia?*cough + fast breathing or lower chest wall indrawingWhat did the Gambia trial tell us about the epidemiology of Hib pneumonia in West Africa?Hib is responsible for about 20% of radiological pneumonia in Gambian infantsPrevious studies had suggested 5-10% of pneumonia due t

6、o HibVery little “WHO pneumonia” which is not radiologically obvious is due to HibConclusionsPRP-T effectively prevented meningitis and pneumonia due to Hib in The GambiaHib vaccines have been proven in Finland, USA, UK, Chile and other countries Why arent Hib vaccines used everywhere?Why are Hib va

7、ccines not used all over the world?costvaries, currently $2 per doseaffordable for most Asian countriesunderstanding of burden of disease is the major problem in AsiaAsiaMany Asian countries can afford Hib vaccineHib was known to be an important cause of bacterial meningitis in AsiaBut:Microbiologic

8、ally confirmed Hib incidence lower than elsewhere ( one color vaccineAverage age at enrollment (i.e., first vaccine plus 2 week delay): 13 weeksAll incidences are per 100,000 child-yearsPneumonia OutcomesAll incidences are per 100,000 child-yearsPneumonia OutcomesAll incidences are per 100,000 child

9、-yearsMeningitis OutcomesAll incidences are per 100,000 child-yearsMeningitis OutcomesPublished rates of Hib meningitis(Children under 5 years per 100K person-years)Mortality rates are per 100,000 child-yearsMortality after at least 1 doseMortality rates are per 100,000 child-yearsMortality after 3

10、dosesConclusionsHib vaccine not an effective intervention against ALRI (pneumonia) in LombokHib meningitis burden underestimated by microbiology true burden 10X greaterHib vaccine may significantly reduce meningitis mortality1 in 33 unvaccinated children on Lombok develop invasive Hib disease before

11、 age 2.Comparison of Gambia and Lombok ResultsHib vaccine prevents about 20% of radiological pneumonia in Gambian infantsVery little “WHO pneumonia” which is not radiologically obvious is due to HibProtection conferred after 3rd doseHib vaccine prevents little to no radiological pneumonia in Lombok infantsThe predominant pneumonia prevented by Hib vaccine is non-severe WHO pneumonia.Prot